WEREWOLF THERAPEUTICS, INC. Increase (Decrease) in Prepaid Expense and Other Assets
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$636.00 thousand for the 6-month period ending 2026-06-30, per its S-4 filed 2026-09-22.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-09-22
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$475.00K, a 167.38% decline year-over-year.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was -$161.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was -$967.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was -$457.00K.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$1.27M, a 583.59% decline from fiscal 2022.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $262.00K, a 91.47% decline from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $3.07M, a 1635.59% increase from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. increase (decrease) in prepaid expense and other assets for fiscal 2020 was $177.00K.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 3 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$475.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-22 | -$636.00K S-4 · filed 2026-09-22 | -$1.60M derived: sum of 3 quarters · filed 2026-09-22 | -$2.06M derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2026-03-31 | -$161.00K 10-Q · filed 2026-05-07 | -$1.13M derived: sum of 2 quarters · filed 2026-09-22 | -$1.58M derived: sum of 3 quarters · filed 2026-09-22 | -$880.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-12-31 | -$967.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | -$1.42M derived: sum of 2 quarters · filed 2026-09-22 | -$719.00K derived: sum of 3 quarters · filed 2026-09-22 | -$850.00K S-4 · filed 2026-09-22 | ||||
| 2025-09-30 | -$457.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-11-04 | $248.00K derived: sum of 2 quarters · filed 2026-09-22 | $117.00K 10-Q · filed 2025-11-04 | -$46.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-06-30 | $705.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-09-22 | $574.00K S-4 · filed 2026-09-22 | $411.00K derived: sum of 3 quarters · filed 2026-09-22 | -$240.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2025-03-31 | -$131.00K 10-Q · filed 2026-05-07 | -$294.00K derived: sum of 2 quarters · filed 2026-09-22 | -$945.00K derived: sum of 3 quarters · filed 2026-09-22 | -$96.00K derived: sum of 4 quarters · filed 2026-09-22 | ||||
| 2024-12-31 | -$163.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-09-22 | -$814.00K derived: sum of 2 quarters · filed 2026-09-22 | $35.00K derived: sum of 3 quarters · filed 2026-09-22 | -$669.00K S-4 · filed 2026-09-22 | ||||
| 2024-09-30 | -$651.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $198.00K derived: sum of 2 quarters · filed 2025-11-04 | -$506.00K 10-Q · filed 2025-11-04 | -$1.04M derived: sum of 4 quarters · filed 2025-11-04 | ||||
| 2024-06-30 | $849.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $145.00K 10-Q · filed 2025-08-14 | $474.00K 10-Q · filed 2024-08-08 | -$390.00K derived: sum of 3 quarters · filed 2025-08-14 | -$259.00K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$704.00K 10-Q · filed 2025-05-08 | -$1.24M derived: sum of 2 quarters · filed 2025-05-08 | -$1.11M derived: sum of 3 quarters · filed 2025-05-08 | -$546.00K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | -$535.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$404.00K derived: sum of 2 quarters · filed 2025-03-11 | $158.00K derived: sum of 3 quarters · filed 2025-03-11 | -$1.27M 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | $131.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $693.00K derived: sum of 2 quarters · filed 2024-11-07 | -$732.00K 10-Q · filed 2024-11-07 | -$596.00K 10-Q · filed 2023-11-14 | -$3.87M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$863.00K 10-Q · filed 2024-08-08 | -$4.00M derived: sum of 3 quarters · filed 2024-08-08 | -$3.33M derived: sum of 4 quarters · filed 2024-08-08 | ||||
| 2023-03-31 | -$1.43M 10-Q · filed 2024-05-03 | -$1.44M 10-Q · filed 2023-05-11 | -$4.56M derived: sum of 2 quarters · filed 2024-05-03 | -$3.89M derived: sum of 3 quarters · filed 2024-05-03 | $626.00K derived: sum of 4 quarters · filed 2024-05-03 | |||
| 2022-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$2.46M derived: sum of 2 quarters · filed 2024-03-07 | $2.05M derived: sum of 3 quarters · filed 2024-03-07 | $262.00K 10-K · filed 2024-03-07 | $541.00K 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $672.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $5.19M derived: sum of 2 quarters · filed 2023-11-14 | $3.40M 10-Q · filed 2023-11-14 | $2.94M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $4.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $2.73M 10-Q · filed 2023-08-10 | $2.27M derived: sum of 3 quarters · filed 2023-08-10 | $3.11M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$1.79M 10-Q · filed 2023-05-11 | -$2.25M derived: sum of 2 quarters · filed 2023-05-11 | -$1.41M derived: sum of 3 quarters · filed 2023-05-11 | $1.36M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $381.00K derived: sum of 2 quarters · filed 2023-03-23 | $3.15M derived: sum of 3 quarters · filed 2023-03-23 | $3.07M 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | $840.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.61M derived: sum of 2 quarters · filed 2022-11-10 | $3.53M 10-Q · filed 2022-11-10 | $3.72M derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $2.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.69M 10-Q · filed 2022-08-11 | $2.88M derived: sum of 3 quarters · filed 2022-08-11 | $2.92M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$81.00K 10-Q · filed 2022-05-10 | $111.00K derived: sum of 2 quarters · filed 2022-05-10 | $151.00K derived: sum of 3 quarters · filed 2022-05-10 | $119.00K derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $232.00K derived: sum of 2 quarters · filed 2022-03-24 | $200.00K derived: sum of 3 quarters · filed 2022-03-24 | $177.00K 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $8.00K derived: sum of 2 quarters · filed 2021-11-10 | -$15.00K 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | -$32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$55.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$23.00K 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |